ReviewBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine2026
Nano-enabled strategies for iron deficiency and iron deficiency anemia: iron-based nanoparticles for supplementation, bioavailability, and food fortification-a narrative review.
Review in Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Iron deficiency and iron deficiency anemia (IDA) remain highly prevalent worldwide and are associated with substantial morbidity, especially among infants, children, women of reproductive age, and individuals with chronic diseases. Conventional oral iron salts and food fortification strategies are often limited by gastrointestinal side effects, poor adherence, and unfavorable sensory changes in fortified foods. Nano-enabled iron formulations have been proposed to overcome these limitations by improving bioavailability while preserving tolerability and product quality. This narrative review summarizes in vitro, in vivo and human studies on iron oxide, iron oxyhydroxide, ferric phosphate, ferric pyrophosphate and ferrous sulfate nanoparticles used for oral supplementation or food fortification in the context of iron deficiency and IDA. Overall, nano-sized iron sources tend to show improved iron bioaccessibility and relative bioavailability than their bulk or conventional counterparts, particularly for poorly soluble compounds, and several preparations appear to reduce gastrointestinal intolerance and sensory changes in foods. Early human data suggest that selected nano-iron formulations can approach the hematological efficacy of ferrous sulfate while offering technological advantages for incorporation into complex food matrices. However, most evidence still derives from short-term or preclinical studies, and important gaps remain regarding long-term safety, organ-specific accumulation, effects on the gut microbiota and performance in diverse at-risk populations. Future work should prioritize well-designed clinical trials, standardized physicochemical and toxicological characterization, and clear regulatory guidance to support the safe and effective integration of nano-enabled iron formulations into nutritional strategies against iron deficiency.
Indexed as
Identifiers
42496789What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.